Headquartered in Boston, Animal Biosciences focuses on improving the health and longevity of companion animals. Its CEO, Doug Korn, has experience in the pet food industry.

The company intends to develop mitochondrial and metabolic treatments for animals, both to prolong the healthy lifespan of pets and to use what it has learned from animal trials to support the other, human-focused companies that are part of the Life Biosciences group.

Animal Biosciences is a daughter company of Life Biosciences, which owns multiple rejuvenation biotechnology companies, each focusing on a different hallmark of aging.